<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Five patients with <z:hpo ids='HP_0012115'>hepatitis</z:hpo>-associated <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> were transplanted with HLA-identical, mixed lymphocyte culture-compatible sibling marrow </plain></SENT>
<SENT sid="1" pm="."><plain>One patient who had suffered from severe <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> died from <z:mp ids='MP_0001915'>intracranial bleeding</z:mp> at 42 months following the transplant </plain></SENT>
<SENT sid="2" pm="."><plain>The other four patients are surviving from 15 to 54 months after transplant with a median follow-up of 21 months </plain></SENT>
<SENT sid="3" pm="."><plain>Previous hepatic damage from <z:hpo ids='HP_0006562'>viral hepatitis</z:hpo> and liver function abnormalities existing at the time of grafting do not appear to increase the risk of hepatic venocclusive disease or the side effects of <z:chebi fb="0" ids="4031">ciclosporin</z:chebi> in patients with <z:hpo ids='HP_0012115'>hepatitis</z:hpo>-associated <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
</text></document>